Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Keros Therapeutics (KROS) Tax Rate (2020 - 2025)

Keros Therapeutics posted quarterly Tax Rate of 6.06% for Q4 2025, up 672.0% year-on-year from 0.79% in Q4 2024, and down 62.95% on a QoQ basis from 16.36% in Q3 2025.

Keros Therapeutics (KROS) has 4 years of Tax Rate data on file, last reported at 6.06% in Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate rose 672.0% year-over-year to 6.06%; the trailing twelve-month figure through Dec 2025 stood at 5.31% (up 547.0% YoY), and the FY2025 full-year result was 5.31%, up 547.0% from the prior year.
  • Tax Rate for Q4 2025 stood at 6.06%, down from 16.36% in the prior quarter.
  • Across five years, Tax Rate topped out at 16.36% in Q3 2025 and bottomed at 40.46% in Q4 2021.
  • The 3-year median for Tax Rate is 3.12% (2021), against an average of 0.72%.
  • The widest annual swing landed in 2021, when Tax Rate slumped 174 bps; it then jumped 672 bps in 2025.
  • A 3-year view of Tax Rate shows it stood at 40.46% in 2021, then soared by 98 bps to 0.66% in 2024, then surged by 1024 bps to 6.06% in 2025.
  • The last three Tax Rate figures came in at 6.06% (Q4 2025), 16.36% (Q3 2025), and 6.75% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 57.14
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 5.61
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.68
7 Evaxion A 62.56 Bn 62.54 Bn - -6.79
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.51
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7.07
10 Keros Therapeutics 403.85 Mn 116.45 Mn - 6.06

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 6.06
Dec 31, 2025 6.06
Sep 30, 2025 16.36
Sep 30, 2025 16.36
Jun 30, 2025 6.75
Jun 30, 2025 6.75
Mar 31, 2025 6.34
Mar 31, 2025 6.34
Dec 31, 2024 -0.66
Dec 31, 2024 -0.66
Dec 31, 2021 -40.46
Dec 31, 2021 -40.46
Sep 30, 2021 0.19
Sep 30, 2021 0.19
Mar 31, 2021 -0.32
Mar 31, 2021 -0.32
Mar 31, 2020 1.43
Mar 31, 2020 1.43